Angelica
Medicinal Actions
Analysis pending research update.
Primary Conditions Treated
General Dosage
1 tsp powdered leaf, root, or seed/cup of water; 1.5 g root/day; 4.5 g root; 1–2 g root in tea 3 ×/day; 0.5–2 g powdered root; 1–2 g seed day; 2–5 g dry leaf 3 ×/day; 2–5 ml leaf tincture 3 ×/day; 0.5–2 ml root tincture 3 ×/day; 1.5 g root tincture; 2–5 ml leaf extract 3 ×/day; 0.2–5 ml root extract 3 ×/day; 2–4 ml liquid root extract; 2–4 ml liquid herb extract; wineglass of root tea.
Safety & Contraindications
Class 2b, 2d. Contraindicated for peptic ulcer. Commission E reports photosensitivity due to furocoumarins. Furanocoumarins may cause phototoxic dermatosis. Anticoagulant coumarins may interact with anticoagulant therapy, additively or synergistically, or perhaps even antagonistically. Angelica and root oils reported to cause photodermatosis and phototoxicity, respectively. Root oil should be limited to 7800 ppm in skin products when the skin is to be exposed to UV. Root Oil LD50 = 2200 mg/kg orl mouse; LD50 = 1160 mg/kg orl rat; toxic in rats 1870 mg/kg; LD50 = >5000 mg/kg top. rabbit. We may extend to all apiaceous oils Bisset’s comments on celeryseed oil, “The drug is contraindicated in inflammation of the kidneys,” since apiaceous EOs may increase the inflammation as a result of epithelial irritation. Bergapten is a suspected carcinogen. Angelica root, reportedly abortifacient, should not be used in “pregnancy and lactation in amounts exceeding those used in foods”. Canadians list “as an unacceptable non-medicinal ingredient for oral use products”. Do not use if fever, chills, headache, thirst, sweating, and a rapid pulse are present.